Pasar al contenido principal

DISEÑO, PRODUCCION Y CARACTERIZACION DE STENTS AUXETICOS CAPACES DE CRECER CON EL PACIENTE. CARACTERIZACION IN VITRO E IN VIVO DE STENTS EN AORTAS PEDIATRICAS COARTADAS.

PID2021-124868OB-C21

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2021
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSITAT RAMON LLULL, FUNDACIO PRIVADA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 8
Encontrada(s) 1 página(s)

DAU Arxiu Digital de la Universitat Ramon Llull
Publicación Artículo científico (JournalArticle)

A Tunable Soft Silicone Bioadhesive for Secure Anchoring of Diverse Medical Devices to Wet Biological Tissue

  • Singh, Manisha
  • Teodorescu, Debbie
  • Rowlett, Meagan
  • Wang, Sophie X.
  • Balcells, Mercedes
  • Park, Clara
  • Bernardo, Bruno
  • McGarel, Sian
  • Reeves, Charlotte
  • Mehra, Mandeep R.
  • Zhao, Xuanhe
  • Yuk, Hyunwoo
  • Roche, Ellen
Silicone is utilized widely in medical devices for its compatibility with tissues and bodily fluids, making it a versatile material for implants and wearables. To effectively bond silicone devices to biological tissues, a reliable adhesive is required to create a long-lasting interface. BioAdheSil, a silicone-based bioadhesive designed to provide robust adhesion on both sides of the interface is introduced here, facilitating bonding between dissimilar substrates, namely silicone devices and tissues. The adhesive's design focuses on two key aspects: wet tissue adhesion capability and tissue-infiltration-based long-term integration. BioAdheSil is formulated by mixing soft silicone oligomers with siloxane coupling agents and absorbents for bonding the hydrophobic silicone device to hydrophilic tissues. Incorporation of biodegradable absorbents eliminates surface water and controls porosity, while silane crosslinkers provide interfacial strength. Over time, BioAdheSil transitions from nonpermeable to permeable through enzyme degradation, creating a porous structure that facilitates cell migration and tissue integration, potentially enabling long-lasting adhesion. Experimental results demonstrate that BioAdheSil outperforms commercial adhesives and elicits no adverse response in rats. BioAdheSil offers practical utility for adhering silicone devices to wet tissues, including long-term implants and transcutaneous devices. Here, its functionality is demonstrated through applications such as tracheal stents and left ventricular assist device lines., info:eu-repo/semantics/publishedVersion
DAU Arxiu Digital de la Universitat Ramon Llull
Publicación Artículo científico (JournalArticle)

Integrating stent design and microstructural characterization to improve clinical outcomes of bioresorbable stents

  • Canalejo-Codina, Francesc
  • PEGUEROLES, MARTA
  • Garcia Granada, Andres Amador
  • Martorell, Jordi
  • Edelman, Elazer
  • Balcells, Mercedes
Bioresorbable stents were conceived to revolutionize the treatment of cardiovascular diseases. However, their significant benefits were overshadowed by a higher clotting rate compared to permanent implants. This clinical failure is linked to strain-induced microstructural disruptions during fabrication and implantation, resulting in heterogeneous loss of structural integrity. The non-gradual loss of support, combined with faster, localized polymer deterioration, directly contributes to the clinical failure observed in bioresorbable stents. Leveraging this understanding marks a significant advancement toward their safe reintroduction. However, the extent to which a stent’s stress distribution interacts with the polymer’s microstructure remains understudied. This study advances the existing knowledge on bioresorbable stents by establishing a framework for comprehending the microstructural properties that emerge from stent fabrication and implantation, ultimately aiming to improve clinical outcomes. The analysis addresses structural degradation and thrombogenicity of the devices, linking these aspects to the microstructural characteristics of various poly(L-lactide-co-ε-caprolactone) stent configurations. The configuration with the polymer microstructure tailored to the stress profile of the stent design presented the best performance. These findings emphasize the critical need to align the as-manufactured material properties with the stress distribution during implantation and provide powerful tools and strategies to cast bioresorbable stents that outperform current cardiovascular stents., info:eu-repo/semantics/publishedVersion
DAU Arxiu Digital de la Universitat Ramon Llull
Publicación Artículo científico (JournalArticle)

Versatile, elastomeric and degradable polyHIPEs of poly(glycerol sebacate)-methacrylate and their application in vascular graft tissue-engineering

  • Pashneh-Tala, Samand
  • Field, Jonathan
  • Fornesa, Blanca
  • Molins Colomer, Maite
  • Jackson, Caitlin E.
  • Balcells, Mercedes
  • Martorell López, Jordi
  • Claeyssens, Frederik
Polymer scaffolds are an important enabling technology in tissue engineering. A wide range of manufacturing techniques have been developed to produce these scaffolds, including porogen leaching, phase separation, gas foaming, electrospinning and 3D printing. However, all of these techniques have limitations. Delivering suitable scaffold porosity, small feature sizes and macroscopic geometry remain challenging. Here, we present the development of a highly versatile scaffold fabrication method utilising emulsion templating to produce polymerised high internal phase emulsions (polyHIPEs) of the polymer poly(glycerol sebacate) methacrylate (PGS-M). PGS-M is biocompatible, degradable and highly elastic, with tunable mechanical properties. PGS-M was formulated into an emulsion using solvents and surfactants and then photocured into polyHIPE structures. The porosity, degradation behaviour, mechanical properties and biocompatibility of the PGS-M polyHIPEs was investigated. The versatility of the PGS-M polyHIPEs was demonstrated with the production of various complex tubular scaffold shapes, using injection moulding. These shapes were designed for applications in vascular graft tissue engineering and included straight tubes, bends, branches, functioning valves, and a representative aortic arch. The PGS-M polyHIPE scaffolds supported vascular smooth muscle cells (SMCs) in 3D cell culture in a bioreactor., info:eu-repo/semantics/publishedVersion
DAU Arxiu Digital de la Universitat Ramon Llull
Publicación Artículo científico (JournalArticle)

Preclinical evaluation of pediatric polymeric stents in a minimally invasive rabbit model

  • Canalejo-Codina, Francesc
  • Cano Morenilla, Mariola
  • Bonich-Aranda, Mireia
  • López Campillo, Adrián
  • Yugueros, Xavier
  • Mestres, Gaspar
  • PEGUEROLES, MARTA
  • Edelman, Elazer
  • Garcia Granada, Andres Amador
  • Balcells, Mercedes
  • Martorell, Jordi
Stent implantation is standard treatment for pediatric aortic coarctation, but permanent metallic devices do not accommodate somatic growth, causing repeated interventions and long-term complications. Bioresorbable polymeric stents offer temporary support with progressive vascular adaptation, yet in vivo validation remains essential. This study evaluates the procedural performance and in vivo biocompatibility of a next-generation polymeric stent in a minimally invasive rabbit model. A microstructure-based auxetic (MBA) geometry fabricated from poly(L-lactide-co-ε-caprolactone) was optimized to a radial force of 0.98 N/mm at 0.55 maximum strain and implanted via a novel 6F femoral catheterization in New Zealand white rabbits, with solvent-cast direct-write (SCDW) polymeric and Cook Formula 418 metallic stents as controls. Of 24 animals, 22 received 39 stents, with follow-up at 30 min, 14 and 28 days. The implantation and explantation protocol proved feasible and reproducible. No MBA device was dislodged during delivery, vs 36.4% of SCDW devices (p = 0.004); migration did not differ between polymeric and metallic devices (p = 0.686). At 28 days, both platforms achieved complete endothelialization (5.00 ± 0.00), minimal vessel injury (0.33 ± 0.52) and preserved medial architecture. Strut integration was complete for MBA (5.00 ± 0.00) vs partial for SCDW (4.33 ± 0.82), and neointimal inflammation was minimal in both (MBA 1.00 ± 0.00; SCDW 1.17 ± 0.41). Transient mural thrombus at 14 days had resolved by 28 days. Neointimal area was comparable (MBA 2.44 ± 0.08 mm²; SCDW 2.24 ± 0.41 mm²), with higher stenosis in MBA arteries (32.72 ± 3.00% vs 20.85 ± 4.00%). These findings support the early biocompatibility of the MBA platform and validate the model for longitudinal assessment of pediatric vascular devices., info:eu-repo/semantics/publishedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Versatile, elastomeric and degradable polyHIPEs of poly(glycerol sebacate)-methacrylate and their application in vascular graft tissue-engineering

  • Pashneh-Tala, Samand
  • Field, Jonathan
  • Fornesa, Blanca
  • Molins Colomer, Maite
  • Jackson, Caitlin E.
  • Balcells, Mercedes
  • Martorell López, Jordi
  • Claeyssens, Frederik
Polymer scaffolds are an important enabling technology in tissue engineering. A wide range of manufacturing techniques have been developed to produce these scaffolds, including porogen leaching, phase separation, gas foaming, electrospinning and 3D printing. However, all of these techniques have limitations. Delivering suitable scaffold porosity, small feature sizes and macroscopic geometry remain challenging. Here, we present the development of a highly versatile scaffold fabrication method utilising emulsion templating to produce polymerised high internal phase emulsions (polyHIPEs) of the polymer poly(glycerol sebacate) methacrylate (PGS-M). PGS-M is biocompatible, degradable and highly elastic, with tunable mechanical properties. PGS-M was formulated into an emulsion using solvents and surfactants and then photocured into polyHIPE structures. The porosity, degradation behaviour, mechanical properties and biocompatibility of the PGS-M polyHIPEs was investigated. The versatility of the PGS-M polyHIPEs was demonstrated with the production of various complex tubular scaffold shapes, using injection moulding. These shapes were designed for applications in vascular graft tissue engineering and included straight tubes, bends, branches, functioning valves, and a representative aortic arch. The PGS-M polyHIPE scaffolds supported vascular smooth muscle cells (SMCs) in 3D cell culture in a bioreactor., info:eu-repo/semantics/publishedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Preclinical evaluation of pediatric polymeric stents in a minimally invasive rabbit model

  • Canalejo-Codina, Francesc
  • Cano Morenilla, Mariola
  • Bonich-Aranda, Mireia
  • López Campillo, Adrián
  • Yugueros, Xavier
  • Mestres, Gaspar
  • PEGUEROLES, MARTA
  • Edelman, Elazer
  • Garcia Granada, Andres Amador
  • Balcells, Mercedes
  • Martorell, Jordi
Stent implantation is standard treatment for pediatric aortic coarctation, but permanent metallic devices do not accommodate somatic growth, causing repeated interventions and long-term complications. Bioresorbable polymeric stents offer temporary support with progressive vascular adaptation, yet in vivo validation remains essential. This study evaluates the procedural performance and in vivo biocompatibility of a next-generation polymeric stent in a minimally invasive rabbit model. A microstructure-based auxetic (MBA) geometry fabricated from poly(L-lactide-co-ε-caprolactone) was optimized to a radial force of 0.98 N/mm at 0.55 maximum strain and implanted via a novel 6F femoral catheterization in New Zealand white rabbits, with solvent-cast direct-write (SCDW) polymeric and Cook Formula 418 metallic stents as controls. Of 24 animals, 22 received 39 stents, with follow-up at 30 min, 14 and 28 days. The implantation and explantation protocol proved feasible and reproducible. No MBA device was dislodged during delivery, vs 36.4% of SCDW devices (p = 0.004); migration did not differ between polymeric and metallic devices (p = 0.686). At 28 days, both platforms achieved complete endothelialization (5.00 ± 0.00), minimal vessel injury (0.33 ± 0.52) and preserved medial architecture. Strut integration was complete for MBA (5.00 ± 0.00) vs partial for SCDW (4.33 ± 0.82), and neointimal inflammation was minimal in both (MBA 1.00 ± 0.00; SCDW 1.17 ± 0.41). Transient mural thrombus at 14 days had resolved by 28 days. Neointimal area was comparable (MBA 2.44 ± 0.08 mm²; SCDW 2.24 ± 0.41 mm²), with higher stenosis in MBA arteries (32.72 ± 3.00% vs 20.85 ± 4.00%). These findings support the early biocompatibility of the MBA platform and validate the model for longitudinal assessment of pediatric vascular devices., info:eu-repo/semantics/publishedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

A Tunable Soft Silicone Bioadhesive for Secure Anchoring of Diverse Medical Devices to Wet Biological Tissue

  • Singh, Manisha
  • Teodorescu, Debbie
  • Rowlett, Meagan
  • Wang, Sophie X.
  • Balcells, Mercedes
  • Park, Clara
  • Bernardo, Bruno
  • McGarel, Sian
  • Reeves, Charlotte
  • Mehra, Mandeep R.
  • Zhao, Xuanhe
  • Yuk, Hyunwoo
  • Roche, Ellen
Silicone is utilized widely in medical devices for its compatibility with tissues and bodily fluids, making it a versatile material for implants and wearables. To effectively bond silicone devices to biological tissues, a reliable adhesive is required to create a long-lasting interface. BioAdheSil, a silicone-based bioadhesive designed to provide robust adhesion on both sides of the interface is introduced here, facilitating bonding between dissimilar substrates, namely silicone devices and tissues. The adhesive's design focuses on two key aspects: wet tissue adhesion capability and tissue-infiltration-based long-term integration. BioAdheSil is formulated by mixing soft silicone oligomers with siloxane coupling agents and absorbents for bonding the hydrophobic silicone device to hydrophilic tissues. Incorporation of biodegradable absorbents eliminates surface water and controls porosity, while silane crosslinkers provide interfacial strength. Over time, BioAdheSil transitions from nonpermeable to permeable through enzyme degradation, creating a porous structure that facilitates cell migration and tissue integration, potentially enabling long-lasting adhesion. Experimental results demonstrate that BioAdheSil outperforms commercial adhesives and elicits no adverse response in rats. BioAdheSil offers practical utility for adhering silicone devices to wet tissues, including long-term implants and transcutaneous devices. Here, its functionality is demonstrated through applications such as tracheal stents and left ventricular assist device lines., info:eu-repo/semantics/publishedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Integrating stent design and microstructural characterization to improve clinical outcomes of bioresorbable stents

  • Canalejo-Codina, Francesc
  • PEGUEROLES, MARTA
  • Garcia Granada, Andres Amador
  • Martorell, Jordi
  • Edelman, Elazer
  • Balcells, Mercedes
Bioresorbable stents were conceived to revolutionize the treatment of cardiovascular diseases. However, their significant benefits were overshadowed by a higher clotting rate compared to permanent implants. This clinical failure is linked to strain-induced microstructural disruptions during fabrication and implantation, resulting in heterogeneous loss of structural integrity. The non-gradual loss of support, combined with faster, localized polymer deterioration, directly contributes to the clinical failure observed in bioresorbable stents. Leveraging this understanding marks a significant advancement toward their safe reintroduction. However, the extent to which a stent’s stress distribution interacts with the polymer’s microstructure remains understudied. This study advances the existing knowledge on bioresorbable stents by establishing a framework for comprehending the microstructural properties that emerge from stent fabrication and implantation, ultimately aiming to improve clinical outcomes. The analysis addresses structural degradation and thrombogenicity of the devices, linking these aspects to the microstructural characteristics of various poly(L-lactide-co-ε-caprolactone) stent configurations. The configuration with the polymer microstructure tailored to the stress profile of the stent design presented the best performance. These findings emphasize the critical need to align the as-manufactured material properties with the stress distribution during implantation and provide powerful tools and strategies to cast bioresorbable stents that outperform current cardiovascular stents., info:eu-repo/semantics/publishedVersion